BioWorld

Feb. 19, 2002

View Archived Issues

Curis Restructuring Includes Cutting Programs, Employees

Curis Inc. said it intends to cut employees and expenses as part of its effort to realign research and development programs to focus on signaling pathways and stem cell technology. (BioWorld Today) Read More

Repligen Begins Phase III Trials Of Secretin In Autistic Children

Read More

French Drug, Aimed At All-New Target, Cured Monkeys Infected With Dire Plasmodium Parasite

Read More

Cellomics Series D To Raise $20M For Screening Platform

Read More

Holiday Notice

Read More

U.S. Patent Disclosures

Read More

Other News To Note

Read More